RESIGRATINIB

UNII:	W728TB393W
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₆H₂₇F₂N₇O₃
Preferred Substance Name:	RESIGRATINIB
InChIKey:	YXVDEILMUVTDMK-JKSUJKDBSA-N
GSRS Full Record:	W728TB393W i

2750709-91-0
1H-Pyrazole-4-carboxamide, 3-[2-(1-cyclopropyl-4,6-difluoro-1H-benzimidazol-5-yl)ethynyl]-1-[(3S,5R)-5-(methoxymethyl)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]-5-(methylamino)-
3-[2-(1-Cyclopropyl-4,6-difluoro-1H-benzimidazol-5-yl)ethynyl]-1-[(3S,5R)-5-(methoxymethyl)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]-5-(methylamino)-1H-pyrazole-4-carboxamide
3-[2-(1-cyclopropyl-4,6-difluorobenzimidazol-5-yl)ethynyl]-1-[(3S,5R)-5-(methoxymethyl)-1-prop-2-enoylpyrrolidin-3-yl]-5-(methylamino)pyrazole-4-carboxamide
Resigratinib
resigratinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RESIGRATINIB

Synonyms and Mappings

Resources